Vascular Biogenics Stock Predictions

Healthcare > Biotechnology

Buy VBLT

*Your capital is at risk

$0.156

+0 (+0%)

At Close: Jan 12, 2024

Currently predicting for Tue, 9 Jun 2026

VBLT Live board

Community Bull/Bear

Target Next close

Join the VBLT prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

VBLT Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For VBLT

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

VBLT Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT VASCULAR BIOGENICS LTD.

Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables specifically inhibit monocyte migration for immune-inflammatory appli...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
TPR $140.47	0.306%	Jun 04
N NVRI $19.53	1.79%	May 20
RUN $12.83	4.91%	May 06
GLBE $31.61	1.71%	May 05
SAP $172.39	5.53%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by